A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy

Giada Tisci, Lenka Rajsiglova, Sandra Bibbo, Giovanna Ziccheddu, Elena Ricciardi, Elisabetta Falvo, Vincenzo De Laurenzi, Gianluca Sala, Emily Capone, Gianni Colotti, Alessandro Arcovito, Noah Giacon, Peter Makovický, Leonid Sushytskyi, Pavol Lukac, Luca Vannucci, Patrizio Giacomini, Pierpaolo Ceci

Open source

DOI: 10.1016/j.ijbiomac.2025.142843
Published: 2025-05
Container: International Journal of Biological Macromolecules
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijbiomac.2025.142843,
  title = {A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy},
  author = {Giada Tisci and Lenka Rajsiglova and Sandra Bibbo and Giovanna Ziccheddu and Elena Ricciardi and Elisabetta Falvo and Vincenzo De Laurenzi and Gianluca Sala and Emily Capone and Gianni Colotti and Alessandro Arcovito and Noah Giacon and Peter Makovický and Leonid Sushytskyi and Pavol Lukac and Luca Vannucci and Patrizio Giacomini and Pierpaolo Ceci},
  year = {2025},
  journal = {International Journal of Biological Macromolecules},
  doi = {10.1016/j.ijbiomac.2025.142843},
  url = {https://doi.org/10.1016/j.ijbiomac.2025.142843}
}

RIS

TY  - JOUR
TI  - A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy
AU  - Giada Tisci
AU  - Lenka Rajsiglova
AU  - Sandra Bibbo
AU  - Giovanna Ziccheddu
AU  - Elena Ricciardi
AU  - Elisabetta Falvo
AU  - Vincenzo De Laurenzi
AU  - Gianluca Sala
AU  - Emily Capone
AU  - Gianni Colotti
AU  - Alessandro Arcovito
AU  - Noah Giacon
AU  - Peter Makovický
AU  - Leonid Sushytskyi
AU  - Pavol Lukac
AU  - Luca Vannucci
AU  - Patrizio Giacomini
AU  - Pierpaolo Ceci
PY  - 2025
JO  - International Journal of Biological Macromolecules
DO  - 10.1016/j.ijbiomac.2025.142843
UR  - https://doi.org/10.1016/j.ijbiomac.2025.142843
ER  -

APA

Tisci, G., Rajsiglova, L., Bibbo, S., Ziccheddu, G., Ricciardi, E., Falvo, E., Laurenzi, V. D., Sala, G., Capone, E., Colotti, G., Arcovito, A., Giacon, N., Makovický, P., Sushytskyi, L., Lukac, P., Vannucci, L., Giacomini, P., & Ceci, P. (2025). A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy. International Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2025.142843

Source records

crossref · retrieved 2026-09-26T22:59:27.474Z